COVID-19 Vaccine Booster Shot Preserves T Cells Immune Response Based on Interferon-Gamma Release Assay in Inflammatory Bowel Disease (IBD) Patients on Anti-TNFα Treatment

Immune-modifying treatment in inflammatory bowel disease (IBD) impairs the humoral response. The role of T lymphocytes in this setting is still unclear. This study aims to assess if a booster shot (third dose) of BNT162b2 mRNA COVID-19 vaccine enhanced the humoral response and elicited cellular immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavia, Grazia, Spagnuolo, Rocco, Quirino, Angela, Marascio, Nadia, Giancotti, Aida, Simeone, Silvio, Cosco, Cristina, Tino, Elena, Carrabetta, Federico, Di Gennaro, Gianfranco, Nobile, Carmelo, Bianco, Aida, Matera, Giovanni, Doldo, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051087/
https://www.ncbi.nlm.nih.gov/pubmed/36992175
http://dx.doi.org/10.3390/vaccines11030591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051087/
https://www.ncbi.nlm.nih.gov/pubmed/36992175
http://dx.doi.org/10.3390/vaccines11030591

Ejemplares similares